Differences of Total-tau were mainly attributed to higher levels in SD patients ([T-tau] = 479 pg/ml), compared to controls (p < 0.05) and CBD/PSP (p < 0.05) (see Table 1). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.